China vs Myanmar: Hypertension effective treatment coverage (controlled hypertension)
China
15.6%
in 2019
Myanmar
15.0%
in 2019
China rank
108th
Myanmar rank
110th
Hypertension effective treatment coverage (controlled hypertension) over time
- China
- Myanmar
How they compare
China currently reports 15.6% against 15.0% in Myanmar, a difference of 0.6%.
The two have swapped places 1 time across 30 shared years of data; in 1990 it was Myanmar ahead.
China ranks 108th and Myanmar ranks 110th of 193 countries.
Across the 3 decades both report, China averaged higher in 2 and Myanmar in 1.
Head to head by decade
| Decade | China | Myanmar | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 3.6% | 4.2% | 0.5% | Myanmar |
| 2000s | 8.3% | 7.8% | 0.4% | China |
| 2010s | 14.0% | 13.1% | 1.0% | China |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hypertension effective treatment coverage (controlled hypertension), China or Myanmar?
- China, at 15.6% against 15.0% in Myanmar as of 2019.
- What is the difference in hypertension effective treatment coverage (controlled hypertension) between China and Myanmar?
- 0.6%, with China ahead.
- How many years of comparable data are there for China and Myanmar?
- 30 years are reported by both, from 1990 to 2019.
- How do China and Myanmar rank globally for hypertension effective treatment coverage (controlled hypertension)?
- China ranks 108th and Myanmar ranks 110th of 193 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hypertension effective treatment coverage (controlled hypertension )among adults aged 30-79, age-standardized (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.